ATE324462T1 - Assays zur detektierung von modulatoren der cytoskeletalen funktion - Google Patents

Assays zur detektierung von modulatoren der cytoskeletalen funktion

Info

Publication number
ATE324462T1
ATE324462T1 AT98945872T AT98945872T ATE324462T1 AT E324462 T1 ATE324462 T1 AT E324462T1 AT 98945872 T AT98945872 T AT 98945872T AT 98945872 T AT98945872 T AT 98945872T AT E324462 T1 ATE324462 T1 AT E324462T1
Authority
AT
Austria
Prior art keywords
assay
cytoskeletal
cytoskeletal function
affected
binding
Prior art date
Application number
AT98945872T
Other languages
English (en)
Inventor
Ron Vale
Daniel Pierce
James Spudich
Lawrence S B Goldstein
Original Assignee
Univ Leland Stanford Junior
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Leland Stanford Junior, Univ California filed Critical Univ Leland Stanford Junior
Application granted granted Critical
Publication of ATE324462T1 publication Critical patent/ATE324462T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/42—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving phosphatase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6887—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/43504—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from invertebrates
    • G01N2333/43595—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from invertebrates from coelenteratae, e.g. medusae
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4712—Muscle proteins, e.g. myosin, actin, protein

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Urology & Nephrology (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
AT98945872T 1997-09-04 1998-09-03 Assays zur detektierung von modulatoren der cytoskeletalen funktion ATE324462T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5789597P 1997-09-04 1997-09-04

Publications (1)

Publication Number Publication Date
ATE324462T1 true ATE324462T1 (de) 2006-05-15

Family

ID=22013400

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98945872T ATE324462T1 (de) 1997-09-04 1998-09-03 Assays zur detektierung von modulatoren der cytoskeletalen funktion

Country Status (8)

Country Link
EP (1) EP1009853B1 (de)
JP (1) JP2001525535A (de)
AT (1) ATE324462T1 (de)
AU (1) AU744881B2 (de)
CA (1) CA2300869A1 (de)
DE (1) DE69834335T2 (de)
ES (1) ES2263218T3 (de)
WO (1) WO1999011814A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19938369B4 (de) * 1999-08-09 2004-08-19 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Verfahren und Vorrichtung zur Erfassung von Molekülwechselwirkungen über molekulare Motoren
ATE360707T1 (de) * 2000-02-07 2007-05-15 Remedios Cristobal Guiller Dos Biomolekularer toxizitätstest
FR2806303B1 (fr) * 2000-03-17 2002-09-27 Inst Nat Sante Rech Med Composes capables de se lier a des proteines constituantes ou associees aux elements du cytosquelette et leurs applications pour la fabrication de medicaments
AUPQ914600A0 (en) * 2000-08-02 2000-08-24 Swinburne University Of Technology Sensor
DE10045808C2 (de) * 2000-09-07 2002-08-08 Imb Inst Fuer Molekulare Biote Verfahren zur Detektion der Aktivität von Wirkstoffen
US7033832B2 (en) 2000-10-13 2006-04-25 University Of Medicine And Dentistry Of New Jersey Endothelial cell—cell cohesion
US6610525B1 (en) 2000-11-22 2003-08-26 Cytokinetics, Inc. Motor proteins and methods for their use
US6673332B1 (en) 2000-11-22 2004-01-06 The Regents Of The University Of California Assays for inhibitors of neuronal transport of Alzheimer's amyloid precursor protein
US6617144B1 (en) 2000-11-22 2003-09-09 Cytokinetics, Inc. Motor proteins and methods for their use
US20030032771A1 (en) * 2001-02-14 2003-02-13 Sharp David J. Peptide inhibitors of cellular proliferation
FR2825928B1 (fr) * 2001-06-18 2004-04-02 Ecole Norm Superieure Cachan Composition pharmaceutique pour le diagnostic, la prevention ou le traitement d'une pathologie tumorale, comprenant un agent modulateur de l'etat polymerisation de l'actine
EP1281963A3 (de) * 2001-07-30 2003-03-19 Warner-Lambert Company Verfahren zum Screening von Verbindungen, die die Wechselwirkung zwischen Prolin-reichen Peptiden und Peptiden, die eine SH3-Domäne umfassen, inhibieren
EP1281962A1 (de) * 2001-07-30 2003-02-05 Warner-Lambert Company Verfahren zum Screening von Verbindungen, die die Wechselwirkung zwischen Prolin-reichen Peptiden und Peptiden, die eine SH3-Domäne umfassen, inhibieren
FR2849203B1 (fr) 2002-12-19 2005-02-18 Bioalliance Pharma Methode d'analyse de l'agressivite tumorale de cellules cancereuses comprenant la mesure de la quantite d'actine polymerisee a l'etat stationnaire
ATE494549T1 (de) * 2003-04-16 2011-01-15 Ono Pharmaceutical Co Screening-verfahren für heilmittel gegen herzkrankheit und medizinische zusammensetzung zur behandlung von herzkrankheit
US7211407B2 (en) 2003-07-15 2007-05-01 Chan Test, Inc. High throughput assay systems and methods for identifying agents that alter surface expression of integral membrane proteins
JP2006246792A (ja) * 2005-03-10 2006-09-21 Bussan Nanotech Research Institute Inc 微生物検出方法及び溶菌試薬
EP3433263A4 (de) * 2016-03-24 2019-10-23 Marquette University Quantitative flagellare fluoreszenzmarker und standards

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE386115T1 (de) * 1991-12-06 2008-03-15 Max Planck Gesellschaft Verwendung von proteinkinasen zur diagnose und behandlung der alzheimer krankheit
US5527773A (en) * 1993-08-25 1996-06-18 United States Of America Use of synthetic peptides to disrupt the cytoskeleton
GB9506197D0 (en) * 1995-03-27 1995-05-17 Hoffmann La Roche Inhibition of tau-tau association.

Also Published As

Publication number Publication date
WO1999011814A1 (en) 1999-03-11
EP1009853B1 (de) 2006-04-26
EP1009853A4 (de) 2002-04-24
AU744881B2 (en) 2002-03-07
CA2300869A1 (en) 1999-03-11
EP1009853A1 (de) 2000-06-21
DE69834335D1 (de) 2006-06-01
AU9301898A (en) 1999-03-22
ES2263218T3 (es) 2006-12-01
JP2001525535A (ja) 2001-12-11
DE69834335T2 (de) 2007-05-03

Similar Documents

Publication Publication Date Title
ATE324462T1 (de) Assays zur detektierung von modulatoren der cytoskeletalen funktion
DE69214906D1 (de) Homogene Immunotests unter Verwendung von Enzym-Inhibitoren
EP1456652A4 (de) Immunzellenaktivierung modulierende substanzen und verwendungsverfahren dafür
DK0943097T3 (da) Fremgangsmåde til at påvise IgE
DE3688184D1 (de) Verfahren zum nachweis von spezifischen bindemitteln und ihren korrespondierenden bindbaren stoffen.
ATE187501T1 (de) Verfahren zur erkennung von ligandenpaar bindung mit erhöter empfindlichkeit
ATE473754T1 (de) Verfahren zur manipulation der zelldifferenzierung
ATE239912T1 (de) Verfahren und vorrichtung zur referenzierung von fluoreszenzintensitätssignalen
DE60045586D1 (de) Testverfahren zur messung der phosphorylierung
ATE461450T1 (de) Verwendung von kontrollflächen zur detektion von störproben in einem nachweisverfahren
ATE138205T1 (de) Verfahren zum nachweis von phosphoryliertes tyrosin enthaltenden proteinen
NO831566L (no) Proeve for esteraseaktivitet i en vaeskeproeve.
ATE404692T1 (de) Screening-verfahren zur identifizierung von tau- protein modulierenden substanzen.
ATE333510T1 (de) Enzymatische messung von mycophenolsäure
DE69928250D1 (de) Analytisches verfahren unter verwendung von multipelviren-markierung
AU6453899A (en) Method for detecting an analyte and kit
ATE15387T1 (de) Verfahren zum bestimmen von enzym-inhibitorkomplexen.
FI973561A7 (fi) Menetelmä ja yhdisteitä analysoitavien aineiden määrittämiseksi remane nssimittausten avulla ja mainittujen yhdisteiden käyttö
ATE284955T1 (de) Map-kinase: polypeptide, polynukleotide und ihre verwendung
ES2112898T3 (es) Metodo de ensayo.
ATE280836T1 (de) Test zur gleichzeitigen messung von verschiedenen enzymatischen aktivitäten
ATE323286T1 (de) Verfahren zum bestimmen von autoantikörpern
ATE354090T1 (de) Verfahren zum bestimmen von crp mit hilfe von phosphorylcholin
DE3850346D1 (de) Verfahren zur Selbstdurchführung von Enzymkinetik.
WO2004078783A3 (en) Enzymes involved in apoptosis

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties